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1. IdentIfy PatIents Most at 
RIsk foR develoPIng Pa-akI
It is generally agreed that not all patients 
are at equal risk for PA-AKI. Figure 1 de-
scribes the pathogenesis of this form of AKI 
and divides it between patient-related fac-
tors and procedure-related factors.
Central to the heightened risk of this 
form of AKI is a vulnerable kidney. The 
kidney may be vulnerable because of he-
modynamic alterations that either decrease 
blood flow (for example congestive heart 
failure) or perfusion pressure (hypotension), 
and/or impair the renal vasculature’s ability 
to respond to contrast-induced decreases in 
blood flow (for example, renal insufficiency, 
diabetes) or drugs such as nonsteroidal anti-
inflammatory drugs (NSAIDs) and renin-
angiotensin-aldosterone system (RAAS) in-
hibitors. Chronic kidney disease is associated 
with both vascular changes and decreases in 
renal reserve that also make the kidney more 
vulnerable to subsequent injury.
A number of risk models have been pre-
sented to enable anticipation of kidney in-
jury and to focus prophylactic efforts on 
those more in danger of developing PA-
AKI. In cardiology, the most widely used 
IntRoduCtIon
The association of a decrease in glo-
merular filtration rate following the ad-
ministration of iodinated contrast was 
first described over 60 years ago [1]. The 
name has changed from contrast-induced 
nephropathy (CIN) to contrast-associated 
acute kidney injury (CA-AKI) to post-an-
giography acute kidney injury (PA-AKI), 
reflecting an ongoing controversy regard-
ing the association. Since the original 
publication, over 1700 publications have 
documented this association, attempted 
to unravel the pathophysiologic mecha-
nism, described the short and long-term 
consequences, and advised practitioners 
on how to prevent this association. The 
most common definition is an absolute 
increase in serum creatinine of 0.5 mg/dl 
or a relative increase of 25% compared to 
baseline that occurs over the 48-72 hours 
following exposure to contrast. However, 
many controversies remain. Guidelines 
from the major groups using iodinated 
contrast have been published and revised 
over the years [2,3]. In this brief editorial, 
we will review the three major tenets of 
these guidelines.
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better the outcomes [13]. The mechanism 
of benefit with fluid administration is un-
known, but a growing body of evidence sug-
gests that at least part of the benefit lies in 
inducing a high urine flow rate. This may 
dilute out the contrast in the nephron and 
decrease the contrast contact time with the 
renal tubular epithelium. Additionally, high 
urine output seems to increase blood flow 
in the medulla, the most sensitive part of the 
kidney with respect to ischemia [14]. An 
algorithm for managing patients is shown 
in Figure 2.
ContRoveRsIes
As mentioned above, there are many ar-
eas that are hotly debated. One is whether 
we have grossly overestimated the impact 
of contrast on renal injury. Certainly, in the 
cardiology space, other sources of injury may 
figure 2. Algorithm 
for managing patients 
undergoing exposure to 
contrast media.
ACE inhibitors = 
angiotensin-converting-
enzyme inhibitors; 
ARBs = angiotensin 
receptor blockers; 
NSAIDs = nonsteroidal 
anti-inflammatory drugs
nus removal of contrast [9]. Hemodialysis 
immediately after contrast administration 
has also been proposed [10]. While many 
of these maneuvers do decrease the amount 
of contrast administered, the evidence that 
the incidence of AKI is also reduced is not 
compelling.
3. PRovIde adequate fluId 
Intake
There are many strategies to minimize the 
risk of PA-AKI, but the only consensus in-
volves the use of fluids to induce a high urine 
output. There are many uncertainties about 
this approach, which have been studied in 
high-risk patients. Although intravenous 
fluids have been most often recommended, 
there is increasing evidence that oral fluids 
may be equally efficacious [11]. For intrave-
nous fluids, isotonic saline and isotonic bi-
carbonate have been most often compared 
and there doesn’t seem to be any difference 
in efficacy [12]. The timing of fluid admin-
istration has been less well studied but in 
general, the longer the administration the 
risk model uses a small number of patient- 
and procedure-related factors to divide pa-
tients into 4 categories of risk [4]. The cat-
egories are not only predictive of AKI but 
also the need for dialysis and in-hospital 
mortality. Patients in the 2 highest risk cat-
egories are targeted for specific prophylactic 
interventions (see below).
2. ReduCe the aMount of 
ContRast adMInIsteRed
The evidence from animal and in vitro 
studies suggests that iodinated contrast 
is directly nephrotoxic (see Figure 1) [5]. 
Review of large patient databases indicates 
that patients who receive more contrast have 
a higher incidence of AKI [6]. Therefore, 
another recommendation in the guidelines 
points to using as little contrast as necessary. 
This includes consideration of other imaging 
techniques that don’t require use of contrast. 
There have also been a number of attempts 
to diminish the volume of contrast admin-
istered using pressure sensitive manifolds 
[7], automatic injectors [8], or coronary si-
figure 1. Model of 
post-angiography 
acute kidney injury 
(PA-AKI) pathogenesis 
that emphasizes the 
factors that make the 
kidney vulnerable to 
contrast. How contrast 
gets into body (IV or 
IA) doesn’t alter how it 
gets to the kidney.
ROS = reacting 
oxygen species
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be present such as hemodynamic effects and 
atheromatous embolic disease. While these 
are less of a problem in patients undergo-
ing outpatient CT exams, no difference 
in the incidence of AKI between patients 
receiving contrast-enhanced CT and non-
contrast CT has been reported [15]. These 
two groups have been propensity matched 
on the reasons for the imaging study.
ConClusIon
Post-angiography AKI continues to be 
a concern and much has been learned over 
the past 60 years. A reasonable approach is 
outlined in Figure 2. Central to preparing 
all patients for exposure to contrast is the 
induction of a high urine output. High-risk 
patients should have an assessment of renal 
function in the 72 hours post-exposure to 
ensure that AKI has not occurred.
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